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General methods  
 Unless otherwise stated, all reactions were carried out under an inert atmosphere of dried 
nitrogen, in glassware which had been oven-dried. Reagents were purchased from Sigma-Aldrich, 
Acros, Alfa Aesar, Fisher Scientific, TCI UK or Lancaster Research Chemicals and were not 
purified except where stated. Solvents were purchased anhydrous and stored over molecular 
sieves. Thin layer chromatography was performed on aluminium sheets coated with Merck silica 
gel 60 F254 with visualisation using potassium permanganate solution, phosphomolybdic acid 
and/or scrutinised under 254 nm UV light. Column chromatography was performed using Silica 60 
(35-70 microns) supplied by Fisher unless otherwise stated.  
 Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker Avance 400 
NMR spectrometer (1H NMR at 400 MHz, 13C NMR at 100 MHz) with the appropriate deuterated 
solvent. Chemical shifts in 1H NMR spectra are expressed as ppm downfield from TMS and in 13C 
NMR, are relative to internal standard, and reported as singlet (s), doublet (d), triplet (t), quartet (q) 
and combinations thereof, or multiplet (m). Coupling constants (J) are quoted in Hz and are 
averaged between coupling partners and rounded to the nearest 0.2 Hz. Mass spectrometry was 
performed using a Bruker MicroTOF-Q instrument with electrospray ionisation in the positive 
mode. FT-IR data was acquired using Thermo Electron Corporation Nicolet 380 FTIR with Smart 




1. To a solution of N-(4-trifluoromethoxy)phenyl)ethane-1,2-diamine1 (0.83 g, 3.75 mmol, 1.0 equiv.), K2CO3 
(1.21 g, 8.75 mmol, 2.3 equiv.) and CuSO4.5H2O (9 mg, 0.04 mmol, 0.001 equiv.) in 20.0 mL MeOH under 
an atmosphere of N2 was added imidazole-1-sulfonyl azide hydrochloride2 (0.94 g, 4.50 mmol, 1.2 equiv.) 
portion-wise.  The reaction mixture was stirred at RT for 2 h and then diluted with 60.0 mL H2O, acidified with 
conc. HCl and washed three times with 40.0 mL EtOAc.  The organic layers were combined, dried over 
MgSO4, filtered and concentrated under reduced pressure to yield a crude orange oil. The oil was purified via 
column chromatography using 9:1 PE 40-60 °C: EtOAc to yield N-(2-azido)ethyl-4-(trifluoromethoxy)aniline 
(0.23 g, 0.93 mmol, 25 %) as a pale yellow oil; Rf 0.38 (9:1 PE 40-60 °C:EtOAc); IR νmax/cm-1 3411, 2102, 
1613, 1515, 1250; 1H NMR (400MHz, CDCl3); 7.06 (2H, d, J = 8.5 Hz, H-3 and H-5), 6.61 (2H, d, J = 7.0 Hz, 








(C-2’), 50.4 (C-1’), 113.5 (C-2 and C-6), 119.4 (ArC), 122.6 (C-3 and C-5), 140.9 (Ar(OCF3)), 145.9 (ArC); 
MS m/z [M+H]+ C9H10N4F3O requires 247.08, found 247.08. 
2. To a solution of N-(2-azidoethyl)-4-(trifluoromethoxy)aniline (0.36 g, 1.46 mmol, 1.0 equiv.) and KSCN 
(1.70 g, 17.52 mmol, 12.0 equiv.) in 4.0 mL AcOH was added a solution of Br2 (0.1 mL, 1.46 mmol, 1.0 
equiv.) in 4.0 mL AcOH dropwise.  This was stirred at RT for 2 h.  The reaction mixture was then diluted with 
24.0 mL H2O, neutralised with 30 % NaOH solution and washed twice with EtOAc.  The organic layers were 
combined dried over MgSO4, filtered and concentrated under reduced pressure to yield a crude yellow oil.  
The crude was purified via column chromatography using 100 % EtOAc to yield azide 6, 0.18 g, 0.59 mmol, 
63 %) as a yellow oil; Rf 0.43 (100 % EtOAc); IR νmax/cm-1 2110, 1610, 1584, 1485, 1256; 1H NMR (400MHz, 
CDCl3); 7.20 (1H, bs, H-7), 7.14 (1H, bd, J = 9.0 Hz, H-5), 7.00 (1H, d, J = 9.0 Hz, H-4), 4.14 (2H, t, J = 6.0 
Hz, H-1’), 3.73 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.7 (C-1’), 48.5 (C-2’), 109.7 (C-4), 
115.3 (C-7), 119.7 (C-5), 121.8 (ArC), 123.8 (ArC), 139.2 (ArC), 143.8 (Ar(OCF3)), 161.2 (ArC); MS m/z 
[M+H]+ C10H9N5F3OS requires 304.05, found 304.05. 
 
General Procedure for the [3 + 2] Cycloaddition of Azides and Terminal Alkynes 
To a solution of 6 (1.0 equiv.) and alkyne (1.5 equiv.) in a 1:1 mixture of THF and H2O heated to 20 °C was 
added 1M CuSO4 (aq) (1.0 equiv.) and sodium ascorbate (aq., 1M, freshly prepared) (2.0 equiv.).  The 
reaction was monitored by TLC.  After consumption of azide 6 the reaction mixture was concentrated under 
reduced pressure to remove excess THF.  This was then diluted with 8.0 mL DCM and diluted with 4.0 mL 
conc. NH4OH and left to stir for 30 mins.  The reaction mixture was washed twice with 8.0 mL H2O and once 
with 8.0 mL brine.  The organic layer was collected, dried over MgSO4, filtered and concentrated under 
reduced pressure to yield the crude 1,2,3-triazole, which was further purified via flash column 





Using the general procedure; to a solution of azide 6 (0.27 g, 0.89 mmol, 1.0 equiv.) and phenylacetylene 
(0.2 mL, 1.32 mmol, 1.5 equiv.) in 12.0 mL H2O and 12.0 mL THF heated to 20 °C was added 0.9 mL 1M 
CuSO4 (aq) and 1.8 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
3 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-phenyl-1,2,3-
triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5a, 0.14 g, 0.35 mmol, 39 %) as an off-white solid; 
Rf 0.21 (100 % EtOAc), m.p. 195 - 201 °C; IR νmax/cm-1 3250, 2954, 1615, 1584, 1483, 1259; 1H NMR 
(400MHz, CDCl3); 7.65 (2H, d, J =18.5 Hz, ArH), 7.61 (1H, s, H-5’’), 7.38 (2H, t, J = 7.0 Hz, ArH), 7.33 - 7.29 
(1H, m, ArH), 7.09 (1H, bs, H-7), 6.94 (1H, bd, J = 8.5 Hz, H-5), 6.54 (1H, d, J = 9.0 Hz, H-4), 4.82 (2H, t, J = 
6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.6 (C-2’), 46.9 (C-1’), 109.0 (C-4), 
115.3 (C-7), 119.8 (C-5), 120.8 (C-5’’), 121.7 (ArC), 123.2 (ArC), 125.8 (ArCH), 128.3 (ArCH), 128.8 (ArCH), 
130.2 (ArC), 138.56 (ArC), 143.9 (Ar(OCF3)), 148.2 (ArC), 161.0 (ArC); MS m/z [M+H]+ C18H15F3N5OS 
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Using the general procedure; to a solution of azide 6 (0.22 g, 0.72 mmol, 1.0 equiv.) and 3-phenyl-1-propyne 
(0.1 mL, 1.07 mmol, 1.5 equiv.) in 8.6 mL H2O and 8.6 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
3 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-benzyl-1,2,3-
triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5b, 0.15 g, 0.34 mmol, 50 %) as a pale yellow solid; 
Rf 0.15 (100 % EtOAc), m.p. 103 - 106 °C; IR νmax/cm-1 3232, 3064, 1602, 1580, 1484, 1256; 1H NMR 
(400MHz, CDCl3); 7.24 - 7.20 (3H, m, ArH), 7.10 (1H, bs, H-5’’), 7.00 - 6.99 (2H, m, ArH), 6.96 (1H, s, H-7), 
6.91 (1H, bd, J = 9.0 Hz, H-5), 6.37 (1H, d, J = 9.0 Hz, H-4), 4.71 (2H, t, J = 6.0 Hz, H-1’), 4.37 (2H, t, J = 6.0 
Hz, H-2’), 3.92 (2H, s, H-1’’’); 13C NMR (100MHz, CDCl3); 31.0 (C-1’’’), 42.8 (C-2’), 45.7 (C-1’), 107.8 (C-4), 
114.0 (C-5’’), 118.1 (ArC) 118.7 (C-5), 120.7 (ArC), 121.67 (ArC), 122.1 (C-7), 125.5 (ArCH), 127.5 (ArCH), 
127.5 (ArCH), 137.6 (ArC), 142.7 (Ar(OCF3)), 147.1 (ArC), 159.6 (ArC); MS m/z [M+H]+ C19H17F3N5OS 
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Using the general procedure; to a solution of azide 6 (0.31 g, 1.02 mmol, 1.0 equiv.) and 4-ethynyltoluene 
(0.1 mL, 1.07 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL CuSO4 
(aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 2 h.  
After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(p-tolyl)-1,2,3-
triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5c, 0.17 g, 0.40 mmol, 56 %) as a pale yellow solid; 
Rf 0.27 (100 % EtOAc), m.p. 199 - 203 °C; IR νmax/cm-1 3273, 3014, 2943, 1626, 1586, 1479, 1386, 1252; 1H 
NMR (400MHz, CDCl3); 7.57 (1H, s, H-5’’), 7.54 (2H, d, J = 8.0 Hz, ArH), 7.19 (2H, d, J = 8.0 Hz, ArH), 7.09 
(2H, bs, H-7 and NH), 6.94  (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.8 (2H, t, J = 6.0 Hz, H-
1’), 4.46 (2H, t, J = 6.0 Hz, H-2’), 2.36 (3H, s, Ar(CH3)); 13C NMR (100MHz, CDCl3); 20.2 (Ar(CH3)), 42.6 (C-
2’), 45.8 (C-1’), 108.0 (C-4), 114.2 (C-7), 118.1 (ArC), 118.8 (ArC),  119.4 (C-5), 120.6 (C-5’’), 122.2 (ArC), 
124.6 (ArCH), 126.3 (ArC), 128.4 (ArCH), 137.1 (ArC), 142.8 (Ar(OCF3)), 147.2 (ArC), 159.8 (ArC); MS m/z 
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 3-(2-(4-(m-Tolyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5d 
 
Using the general procedure; to a solution of azide 6 (0.18 g, 0.60 mmol, 1.0 equiv.) and 3-ethynyltoluene 
(0.1 mL, 0.90 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.6 mL 1M 
CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(m-tolyl)-1,2,3-
triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5d, 0.15 g, 0.36 mmol, 59 %) as a pale yellow solid; 
Rf  (100 % EtOAc), m.p. 178 - 182 °C; IR νmax/cm-1 3280, 2954, 1625, 1586, 1480, 1384, 1267; 1H NMR 
(400MHz, CDCl3); 7.60 (1H, s, ArH), 7.52 (1H, s, H-5’’), 7.41 (1H, d, J = 7.5 Hz, ArH), 7.26 (1H, appt, J = 6.5 
Hz, ArH), 7.13 (1H, d, J = 7.5 Hz, ArH), 7.09 (2H, bs, H-7 and NH), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, 
J = 9.0 Hz, H-4), 4.81 (2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’), 2.37 (3H, s, Ar(CH3)); 13C NMR 
(100MHz, CDCl3); 20.3 (Ar(CH3)), 42.6 (C-2’), 46.9 (C-1’), 108.0 (C-4), 114.2 (C-7), 118.1 (ArC), 118.8 (ArC), 
119.7 (C-5), 120.6 (C-5’’), 122.2 (ArCH), 123.2 (ArC) 125.4 (ArCH), 127.6 (ArCH), 128.0 (ArCH), 129.0 
(ArC), 137.5 (ArC), 142.8 (Ar(OCF3)), 147.2 (ArC), 159.8 (ArC); MS m/z [M+H]+ C19H17F3N5OS requires 
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 3-(2-(4-(o-Tolyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5e 
 
Using the general procedure; to a solution of azide 6 (0.22 g, 0.73 mmol, 1.0 equiv.) and 2-ethynyltoluene 
(0.1 mL, 1.09 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 and 1.5 mL freshly prepared 1M sodium ascorbate dropwise.  This was stirred at 20 °C for 2 h.  After 
work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(o-tolyl)-1,2,3-triazolyl)ethyl)-6-
(trifluoromethoxy)benzothiazol-2-imine (5e, 0.11 g, 0.27 mmol, 37 %) as an off-white solid; Rf 0.15 (100 % 
EtOAc), m.p. 165 - 170 °C; IR νmax/cm-1 3227, 3077, 2960, 1601, 1581, 1484, 1382, 1260; 1H NMR 
(400MHz, CDCl3); 7.45 - 7.42 (2H, m, ArH and H-5’’), 7.24 - 7.19 (3H, m, ArH), 7.09 (2H, bs, H -7 and NH), 
6.92 (1H, d, J = 8.5 Hz, H-5), 6.44 (1H, d, J = 9.0 Hz, H-4), 4.86 (2H, t, J = 5.5 Hz, H-1’), 4.47 (2H, t, H-2’, J = 
5.5 Hz), 2.16 (3H, s, Ar(CH3)); 13C NMR (100MHz, CDCl3); 19.6 (Ar(CH3)), 42.9 (C-2’), 45.9 (C-1’), 107.8 (C-
4), 114.2 (C-7), 118.07 (ArC), 118.9 (C-5), 120.6 (ArC), 121.9 (C-5’’), 122.1 (ArC),  125.0 (ArCH), 127.3 
(ArCH), 128.0 (ArCH), 128.5 (ArC), 129.6 (ArCH), 134.6 (ArC), 137.66 (ArC), 142.8 (Ar(OCF3)), 146.4 (ArC); 
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Using the general procedure; to a solution of azide 6 (0.17 g, 0.55 mmol, 1.0 equiv.) and 1-
ethynylnapthalene (0.1 mL, 0.83 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.6 mL 1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-
(napthalen-1-yl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5f, 0.15 g, 0.34 mmol, 61 %) 
as a red solid; Rf 0.20 (100 % EtOAc), m.p. 161 - 163 °C; IR νmax/cm-1 3273, 3014, 1632, 1582, 1481, 1254; 
1H NMR (400MHz, CDCl3); 7.87 - 7.84 (3H, m, ArH), 7.60 (1H, s, H-5’’), 7.52 - 7.39 (4H, m, ArH), 7.12 (1H, s, 
H-7), 6.95 (1H, d, J = 8.5 Hz, H-5), 6.49 (1H, d, J = 9.0 Hz, H-4), 4.93 (2H, t, J = 5.5 Hz, H-1’), 4.52 (2H, t, J 
= 5.5 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.9 (C-2’), 46.0 (C-1’), 107.8 (C-4), 114.2 (C-7), 118.8 (C-4), 
120.6 (ArC), 122.2 (ArC), 122.8 (C-5’’), 123.9 (ArCH), 124.2 (ArCH), 125.0 (ArCH), 125.5 (ArCH), 126.2 
(ArCH), 126.6 (ArC), 127.3 (ArCH), 127.9 (ArCH), 130.0 (ArC), 132.7 (ArC), 138.6 (ArC), 142.8 (Ar(OCF3)), 
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Using the general procedure; to a solution of azide 6 (0.19 g, 0.62 mmol, 1.0 equiv.) and 1-ethyl-4-
ethynylbenzene (0.1 mL, 0.93 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.6 mL 1M CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
ethylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5g, 0.17 g, 0.40 mmol, 67 %) as 
an off-white solid; Rf 0.20 (100 % EtOAc), m.p. 189 - 193 °C; IR νmax/cm-1 3278, 3044, 2930, 1626, 1585, 
1481, 1256; 1H NMR (400MHz, CDCl3); 7.57  (3H, d, J = 7.0 Hz, H-5’’ and ArH), 7.21 (2H, d, J = 8.0 Hz, 
ArH), 7.09 (1H, s, H-7), 6.93 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, t, J = 6.0 Hz, H-
1’), 4.46 (2H, t, J = 6.0 Hz, H-2’), 2.66 (2H, q, J = 7.5 Hz, H-1’’’’), 1.24 (3H, t, J = 7.5 Hz, H-2’’’’); 13C NMR 
(100MHz, CDCl3); 14.5 (C-2’’’’), 27.6 (C-1’’’’), 42.6 (C-2’), 45.8 (C-1’), 108.0 (C-7), 114.2 (C-4), 118.8 (C-5), 
119.5 (C-5’’), 120.6 (ArC), 122.2 (ArC), 124.7 (ArCH), 126.5 (ArC), 127.3 (ArCH), 137.6 (ArC), 142.8 
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 3-(2-(4-(4-Propylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5h 
 
Using the general procedure; to a solution of azide 6 (0.18 g, 0.56 mmol, 1.0 equiv.) and 1-ethynyl-4-
propylbenzene (0.1 mL, 0.87 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.6 mL 1M CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
propylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5h, 0.19 g, 0.42 mmol, 75 %) as 
an off-white solid; Rf 0.23 (100 % EtOAc), m.p. 190 - 196 °C; IR νmax/cm-1 3274, 3043, 2931, 1626, 1585, 
1480, 1252; 1H NMR (400MHz, CDCl3); 7.59 (3H, d, J = 8.0 Hz, H-5’’ and ArH), 7.19 (2H, d, J = 8.0 Hz, ArH), 
7.09 (1H, s, H-7), 6.93 (1H, d, J = 9.0 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, t, J = 6.0 Hz, H-1’), 
4.46 (2H, t, J = 6.0 Hz, H-2’), 2.59 (2H, t, J = 7.5 Hz, H-1’’’’), 1.63 (2H, sext, J = 7.5 Hz, H-2’’’’), 0.94 (3H, t, J 
= 7.5 Hz, H-3’’’’); 13C NMR (100MHz, CDCl3); 12.7 (C-3’’’’), 23.4 (C-2’’’’), 36.8 (C-1’’’’), 42.6 (C-2’), 45.8 (C-
1’), 108.0 (C-4), 114.2 (C-7), 118.8 (C-5), 119.5 (C-5’’), 120.6 (ArC), 122.2 (ArC), 124.6 (ArCH), 126.6 (ArC), 
127.8 (ArCH), 137.6 (ArC), 141.9 (ArC), 142.8 (Ar(OCF3)), 147.2 (ArC), 159.9 (ArC); MS m/z [M+H]+ 
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 3-(2-(4-(4-Butylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5i 
 
Using the general procedure; to a solution of azide 6 (0.15 g, 0.49 mmol, 1.0 equiv.) and 1-butyl-4-
ethynylbenzene (0.1 mL, 0.74 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.5 mL 1M CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
butylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5i, 0.16 g, 0.35 mmol, 72 %) as a 
pale yellow solid; Rf 0.21 (100 % EtOAc), m.p. 183 - 186 °C; IR νmax/cm-1 3230, 3048, 2967, 1581, 1484, 
1257; 1H NMR (400MHz, CDCl3); 7.58 (1H, s, H-5’’), 7.56 (2H, d, J = 7.5 Hz, ArH), 7.19 (2H, d, J = 7.5 Hz, 
ArH), 7.09 (1H, s, H-7), 6.94 (1H, d, J = 7.5 Hz, H-5), 6.54 (1H, d, J = 8.5 Hz, H-4), 4.81 (2H, bs, H-1’), 4.48 
(2H, bs, H-2’), 2.61 (2H, t, J = 7.5 Hz, H-1’’’’), 1.60 (2H, quin, J = 7.5 Hz, H-2’’’’), 1.36 (2H, sext, J = 7.5 Hz, 
H-3’’’’), 0.92 (3H, t, J = 7.5 Hz, H-4’’’’); 13C NMR (100MHz, CDCl3); 12.9 (C-4’’’’), 21.3 (C-3’’’’), 32.5 (C-2’’’’), 
34.4 (C-1’’’’), 42.6 (C-2’), 45.8 (C-1’), 108.0 (C-4), 114.2 (C-7), 118.8 (C-5), 119.5 (C-5’’), 120.6 (ArC), 122.2 
(ArC), 124.6 (ArCH), 126.5 (ArC), 127.8 (ArCH), 137.6 (ArC), 142.2 (ArC), 142.8 (Ar(OCF3)), 147.3 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.21 g, 0.68 mmol, 1.0 equiv.) and 4-tert-
butylphenylacetylene (0.2 mL, 1.01 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.7 mL 1M CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
(tert-butyl)phenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5j, 0.23 g, 0.50 mmol, 73 
%) as a pale yellow solid; Rf 0.24 (100 % EtOAc), m.p. 176 - 180 °C; IR νmax/cm-1 3321, 3007, 2953, 1604, 
1583, 1483, 1256; 1H NMR (400MHz, CDCl3); 7.58 (3H, d, J = 7.0 Hz, ArH and H-5’’), 7.40 (2H, d, J = 8.0 
Hz, ArH), 7.09 (1H, s, H -7), 6.93 (1H, d, J = 9.0 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, t, J = 6.0 
Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’), 1.32 (9H, s, ArC(CH3)3); 13C NMR (100MHz, CDCl3); 30.2 
(ArC(CH3)3), 33.6 (ArC), 42.6 (C-2’), 45.9 (C-1’), 107.8 (C-4), 114.2 (C-7), 118.8 (C-5), 119.5 (C-5’’), 120.6 
(ArC), 122.2 (ArC), 124.5 (ArCH), 124.7 (ArCH), 126.3 (ArC), 137.6 (ArC), 142.8 (Ar(OCF3)), 147.1 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.17 g, 0.55 mmol, 1.0 equiv.) and 1-ethynyl-4-
pentylbenzene (0.2 mL, 0.82 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.6 mL 1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
pentylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5k, 0.18 g, 0.38 mmol, 68 %) as 
a pale yellow solid; Rf 0.21 (100 % EtOAc), m.p. 184 - 187 °C; IR νmax/cm-1 3276, 3044, 2926, 1626, 1585, 
1481, 1256; 1H NMR (400MHz, CDCl3); 7.59 (1H, s, H-5’’), 7.56 (2H, d, J = 8.0 Hz, ArH), 7.19 (2H, d, J = 8.0 
Hz, ArH), 7.10 (1H, s, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.55 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, t, J = 6.0 
Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’), 2.60 (2H, t, J = 7.5 Hz, H-1’’’’), 1.65 - 1.58 (2H, m, H-2’’’’), 1.33 - 1.32 
(4H, m, H-3’’’’ and H-4’’’’) 0.89 (3H, t, J = 6.5 Hz, H-5’’’’); 13C NMR (100MHz, CDCl3); 13.2 (C-5’’’’), 21.5 (C-
4’’’’), 30.0 (C-2’’’’), 30.4 (C-3’’’’), 34.7 (C-1’’’’), 42.6 (C-2’), 45.8 (C-1’), 108.0 (C-4), 114.2 (C-7), 118.8 (C-5), 
119.4 (C-5’’), 120.6 (ArC), 123.2 (ArC), 124.6 (ArCH), 126.5 (ArC), 127.8 (ArCH), 137.6 (ArC), 142.2 (ArC), 
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Usuiv.ing the general procedure; to a solution of azide 6 (0.18 g, 0.61 mmol, 1.0 eq) and 1-ethynyl-4-
hexylbenzene (0.2 mL, 0.91 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.6 mL 1M CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
hexylphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5l, 0.21 g, 0.44 mmol, 72 %) as 
a pale yellow solid; Rf 0.24 (100 % EtOAc), m.p. 175 - 180 °C; IR νmax/cm-1 3276, 3044, 2926, 1626, 1585, 
1481, 1255; 1H NMR (400MHz, CDCl3); 7.57 (1H, s, H-5’’), 7.55 (2H, d, J = 8.0 Hz, ArH), 7.19 (2H, d, J = 8.0 
Hz, ArH), 7.09 (1H, s, H-7), 6.94 (1H, d, J = 9.0 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, d, J = 6.0 
Hz, H-1’), 4.45 (2H, t, J = 6.0 Hz, H-2’), 2.60 (2H, t, J = 7.5 Hz, H-1’’’’), 1.59 (2H, quin, H-2’’’’), 1.30 (6H, m, 
H-3’’’’, H-4’’’’ and H-5’’’’), 0.88 (3H, t, J = 6.5 Hz, H-6’’’’); 13C NMR (100MHz, CDCl3); 13.1 (C-6’’’’), 21.6 (C-
5’’’’), 27.9 (C-3’’’’), 30.3 (C-2’’’’), 30.7 (C-4’’’’), 34.7 (C-1’’’’), 42.6 (C-2’), 45.8 (C-1’), 108.0 (C-4), 114.2 (C-7), 
118.8 (C-5), 119.4 (C-5’’), 120.6 (ArC), 122.2 (ArC), 124.6 (ArCH), 126.5 (ArC), 127.8 (ArCH), 137.6 (ArC), 
142.2 (ArC), 142.8 (Ar(OCF3)), 147.2 (ArC), 159.8 (ArC); MS m/z [M+H]+ C24H27F3N5OS requires 490.19, 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.67 mmol, 1.0 equiv.) and 2-ethynylanisole 
(0.1 mL, 1.01 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(2-methoxyphenyl)-
1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5m, 0.22 g, 0.52 mmol, 77 %) as a pale yellow 
solid; Rf 0.20 (100 % EtOAc), m.p. 155 - 160 °C; IR νmax/cm-1 3287, 3011, 2835, 1632, 1585, 1481, 1245; 1H 
NMR (400MHz, CDCl3); 8.21 (1H, d, J = 7.5 Hz, ArH), 7.86 (1H, s, H-5’’), 7.29 (1H, appt, J = 8.0 Hz, ArH), 
7.08 (1H, s, C-7), 7.05 (1H, appt, J = 7.5 Hz, ArH), 6.921 (2H, d, J = 8.5 Hz, ArH and C-5), 6.51 (1H, d, J = 
9.0 Hz, C-4), 4.81 (2H, t, J = 6.0 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’), 3.82 (3H, s, Ar(OCH3)); 13C NMR 
(100MHz, CDCl3); 42.6 (C-2’), 45.7 (C-1’), 54.2 (Ar(OCH3)), 108.0 (C-4), 109.7 (ArCH), 114.0 (C-7), 118.0 
(ArC), 118.8 (C-5), 120.0 (ArCH), 120.6 (ArC), 122.1 (ArC), 123.1 (C-5’’), 126.6 (ArCH), 128.0 (ArCH), 137.7 
(ArC), 142.4 (ArC), 142.7 (Ar(OCF3)), 154.5 (ArC), 159.9 (ArC); MS m/z [M+H]+ C19H17F3N5O2S requires 
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 3-(2-(4-(3-Methoxyphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5n 
 
Using the general procedure; to a solution of azide 6 (0.18 g, 0.58 mmol, 1.0 equiv.) and 3-ethynylanisole 
(0.1 mL, 0.87 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.6 mL 1M 
CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(3-methoxyphenyl)-
1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5n, 0.17 g, 0.39 mmol, 67 %) as an off white 
solid; Rf 0.18 (100 % EtOAc), m.p. 170 - 174 °C; IR νmax/cm-1 3253, 3097, 2835, 1606, 1584, 1485, 1258; 1H 
NMR (400MHz, CDCl3); 7.61 (1H, s, H-5’’), 7.28 (2H, d, J = 5.0 Hz, ArH), 7.17 (1H, d, J = 7.5 Hz, ArH), 7.09 
(1H, s, C-7), 6.94 (1H, d, J = 8.5 Hz, C-5), 6.86 (1H, d, J = 7.0 Hz, ArH), 6.54 (1H, d, J = 9.0 Hz, C-4), 4.82 
(2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’), 3.85 (3H, s, Ar(OCH3)); 13C NMR (100MHz, CDCl3); 
42.5 (C-2’), 45.9 (C-1’), 54.3 (Ar(OCH3)), 108.0 (C-4), 109.8 (ArCH), 113.3 (ArCH), 114.2 (C-7), 117.1 
(ArCH), 118.1 (ArC), 118.8 (C-5), 120.0 (C-5’’), 120.6 (ArC), 122.2 (ArC), 128.8 (ArCH), 130.4 (ArC), 137.5 
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 3-(2-(4-(4-Methoxyphenyl)-1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5o 
 
Using the general procedure; to a solution of azide 6 (0.14 g, 0.46 mmol, 1.0 equiv.) and 4-ethynylanisole 
(0.1 mL, 0.69 mmol, 1.5 equiv.) in 5.0 mL H2O and 5.0 mL THF heated to 20 °C was added 0.5 mL 1M 
CuSO4 (aq) and 0.9 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-methoxyphenyl)-
1,2,3-triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5o, 0.09 g, 0.21 mmol, 47 %) an off white 
solid; Rf 0.21 (100 % EtOAc), m.p. 187 - 197 °C; IR νmax/cm-1 3262, 3029, 2835, 1619, 1584, 1485, 1265; 1H 
NMR (400MHz, CDCl3); 7.57 (2H, d, J = 9.0 Hz, ArH), 7.52 (1H, s, H-5’’), 7.09 (1H, s, H-7), 6.94 (1H, d, J = 
8.0 Hz, H-5), 6.91 (2H, d, J = 9.0 Hz, ArH), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.80 (2H, t, J = 6.0 Hz, H-1’), 4.46 
(2H, t, J = 6.0 Hz, H-2’), 3.83 (3H, s, Ar(OCH3)); 13C NMR (100MHz, CDCl3); 42.6 (C-2’), 45.8 (C-1’), 54.3 
(Ar(OCH3)), 108.0 (C-4), 113.2 (ArCH), 114.2 (C-7), 118.1 (ArC), 118.8 (C-5), 119.0 (C-5’’), 121.8 (ArC), 
122.2 (ArC), 126.0 (ArCH), 137.6 (ArC), 142.8 (Ar(OCF3)), 147.0 (ArC), 158.6 (ArC), 159.8 (ArC); MS m/z 
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 4-(1-(2-(2-Imino-6-trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)aniline 5p 
 
Using the general procedure; to a solution of azide 6 (0.24 g, 0.78 mmol, 1.0 equiv.) and 4-ethynylaniline 
(0.14 g, 1.17 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.8 mL 1M 
CuSO4 (aq) and 1.6 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 4-(1-(2-(2-imino-6-
trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)aniline (5p, 0.09 g, 0.21 mmol, 27 %) as a pale 
yellow solid; Rf 0.10 (100 % EtOAc), m.p. 196 - 200 °C; IR νmax/cm-1 3373, 3318, 3028, 1609, 1585, 1484, 
1252; 1H NMR (400MHz, CDCl3); 7.47 (1H, s, H-5’), 7.44 (2H, d, J = 8.5 Hz, ArH), 7.09 (1H, s, H-7’’’), 6.94 
(1H, d, J = 9.0 Hz, H-5’’’) 6.68 (2H, d, J = 8.5 Hz, ArH), 6.53 (1H, d, J = 9.0 Hz, H-4’’’), 4.78 (2H, t, J = 6.0 
Hz, H-1’’), 4.45 (2H, t, J = 6.0 Hz, H-2’’), 3.74 (2H, bs, Ar(NH2)); 13C NMR (100MHz, CDCl3); 43.6 (C-2’’), 
46.8 (C-1’’), 109.1 (C-4’’’), 115.2 (ArCH and C-7’’’), 119.6 (C-5’), 119.9 (C-5’’’), 120.6 (ArC), 121.7 (ArC), 
123.2 (ArC), 127.0 (ArCH), 138.6 (ArC), 143.8 (Ar(OCF3)), 146.6 (ArC), 148.5 (ArC), 160.9 (ArC); MS m/z 
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Using the general procedure; to a solution of azide 6 (0.25 g, 0.82 mmol, 1.0 equiv.) and 3-ethynylaniline (0.1 
mL, 1.23 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.8 mL 1M CuSO4 
(aq) and 1.6 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 2 h.  
After work-up the crude was column purified using 100 % EtOAc to yield 3-(1-(2-(2-imino-6-
trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)aniline (5q, 0.15 g, 0.37 mmol, 45 %) as a pale 
yellow solid; Rf 0.10 (100 % EtOAc), m.p. 196 - 199 °C; IR νmax/cm-1 3461, 3295, 3036, 1620, 1586, 1481, 
1262; 1H NMR (400MHz, CDCl3); 7.60 (1H, s, H-5’), 7.14 (1H, t, J = 7.5 Hz, ArH), 7.10 (2H, s, H-7’’’ and 
ArH), 6.95 (2H, d, J = 8.0 Hz, H-5’’’ and ArH), 6.64 (1H, dd, J = 1.5 Hz and 8.0 Hz, ArH), 6.56 (1H, d, J = 9.0 
Hz, H-4’’’), 5.30 (2H, s. Ar(NH2)), 4.80 (2H, t, J = 6.0 Hz, H-1’’), 4.47 (2H, t, J = 6.0 Hz, H-2’’); 13C NMR 
(100MHz, CDCl3); 42.5 (C-2’’), 45.8 (C-1’’), 108.0 (C-4’’’), 111.2 (ArCH), 114.0 (ArCH), 114.2 (C-7’’’), 115.0 
(ArCH), 118.8 (C-5’’’), 119.8 (C-5’), 120.6 (ArC), 122.2 (ArC), 128.7 (ArCH), 130.1 (ArC), 137.5 (ArC), 142.8 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.65 mmol, 1.0 equiv.) and 2-ethynylaniline (0.1 
mL, 0.97 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M CuSO4 
(aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 2 h.  
After work-up the crude was column purified using 100 % EtOAc to yield 2-(1-(2-(2-imino-6-
trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)aniline (5r, 0.13 g, 0.32 mmol, 49 %) as a pale 
yellow solid; Rf 0.20 (100 % EtOAc), m.p. 193 - 195 °C; IR νmax/cm-1 3345, 3278, 3029, 1610, 1585, 1484, 
1255; 1H NMR (400MHz, CDCl3); 7.63 (1H, s, H-5’), 7.12 - 7.08 (3H, m, H-7’’’ and ArH), 6.96 (1H, d, J = 8.5 
Hz, H-5’’’), 6.73 (1H, d, J = 8.0 Hz, ArH), 6.67 (1H, t, J = 7.5 Hz, ArH), 6.53 (1H, d, J = 9.0 Hz, H-4’’’), 5.24 
(2H, bs, Ar(NH2)), 4.83 (2H, t, J = 6.0 Hz, H-1’’), 4.47 (2H, t, J = 6.0 Hz, H-2’’); 13C NMR (100MHz, CDCl3); 
43.5 (C-2’’), 46.9 (C-1’’), 108.9 (C-4’’’), 113.4 (ArC), 115.3 (C-7’’’), 116.6 (ArCH), 117.4 (ArCH), 119.9 (C-5’’’), 
121.1 (C-5’), 123.3 (ArC), 127.8 (ArCH), 129.2 (ArCH), 138.6 (ArC), 143.9 (Ar(OCF3)), 148.7 (ArC), 154.1 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.67 mmol, 1.0 equiv.) and 4-ethynyl-N,N-
dimethylaniline (0.15 g, 1.01 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.7 mL 1M CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 4-(1-(2-(2-imino-6-
(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)-N,N-dimethylaniline (5s, 0.17 g, 0.39 mmol, 58 
%) as a pale yellow solid; Rf 0.17 (100 % EtOAc), m.p. 214 - 217 °C; IR νmax/cm-1 3246, 2945, 1614, 1584, 
1483, 1251; 1H NMR (400MHz, CDCl3); 7.53 (2H, d, J = 9.0 Hz, ArH), 7.49 (1H, s, H-5’), 7.09 (1H, d, J = 1.5 
Hz, H-7’’’), 6.94 (1H, d, J = 9.0 Hz, H-5’’’), 6.72 (2H, d, J = 9.0 Hz, ArH), 6.55 (1H, d, J = 9.0 Hz, H-4’’’), 4.798 
(2H, t, J = 6.0 Hz, H-1’’), 4.45 (2H, t, J = 6.0 Hz, H-2’’), 2.99 (6H, s, ArN(CH3)2); 13C NMR (100MHz, CDCl3); 
40.5 (ArN(CH3)2), 43.7 (C-2’’), 46.8 (C-1’’), 109.1 (C-4’’’), 112.4 (ArCH), 115.2 (C-7’’’), 118.4 (ArC), 119.3 (C-
5’), 119.9 (C-5’’’), 123.2 (ArC), 126.7 (ArCH), 138.6 (ArC), 143.8 (ArC), 148.6 (ArC), 150.5 (ArC), 160.9 
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Using the general procedure; to a solution of azide 6 (0.25 g, 0.81 mmol, 1.0 equiv.) and 1-chloro-4-
ethynylbenzene (0.17 g, 1.21 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.8 mL 1M CuSO4 (aq) and 1.6 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
chlorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5t, 0.19 g, 0.44 mmol, 55 %) 
as an off-white solid; Rf 0.18 (100 % EtOAc), m.p. 206 -209 °C; IR νmax/cm-1 3255, 3086, 1617, 1586, 1484, 
1237, 827; 1H NMR (400MHz, CDCl3); 7.60 (1H, s, H-5’’), 7.58 (2H, d, J = 5.0 Hz, ArH), 7.35 (2H, d, J = 8.5 
Hz, ArH), 7.09 (1H, s, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.82 (2H, t, J = 6.0 
Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.5 (C-2’), 46.9 (C-1’), 108.9 (C-4), 
115.3 (C-7), 119.9 (C-5), 120.8 (C-5’’), 123.2 (ArC), 127.0 (ArCH), 129.0 (ArCH), 132.9 (ArC), 134.0 (ArC), 
138.5 (ArC), 143.9 (Ar(OCF3)), 147.1 (ArC), 154.7 (ArC), 160.9 (ArC); MS m/z [M+H]+ C18H14ClF3N5OS 
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Using the general procedure; to a solution of azide 6 (0.30 g, 0.98 mmol, 1.0 equiv.) and 3-chloro-1-
ethynylbenzene (0.2 mL, 1.47 mmol, 1.5 equiv.) in 15.0 mL H2O and 15.0 mL THF heated to 20 °C was 
added 1.0 mL 1M CuSO4 (aq) and 2.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(3-
chlorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5u, 0.25 g, 0.57 mmol, 58 %) 
as an off-white solid; Rf 0.23 (100 % EtOAc), m.p. 183 - 187 °C; IR νmax/cm-1 3242, 3043, 1612, 1581, 1481, 
1254, 794; 1H NMR (400MHz, CDCl3); 7.67 (1H, s, ArH), 7.63 (1H, s, H-5’’), 7.53 (1H, d, J = 7.0 Hz, ArH), 
7.33 - 7.26 (2H, m, ArH), 7.10 (1H, s, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.82 
(2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.5 (C-2’), 47.0 (C-1’), 
108.9 (C-4), 115.3 (C-7), 119.9 (C-4), 121.1 (C-5’’), 123.2 (ArC), 123.8 (ArCH), 125.8 (ArCH), 128.3 (ArCH), 
130.1 (ArCH), 131.9 (ArC), 134.8 (ArC), 138.5 (ArC), 143.8 (Ar(OCF3)), 146.9 (ArC), 156.6 (ArC), 160.8 
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Using the general procedure; to a solution of azide 6 (0.17 g, 0.56 mmol, 1.0 equiv.) and 1-chloro-2-
ethynylbenzene (0.1 mL, 0.84 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.6 mL 1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(2-
chlorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5v, 0.13 g, 0.30 mmol, 53 %) 
as a pale yellow solid; Rf 0.30 (100 % EtOAc), m.p. 154 - 157 °C; IR νmax/cm-1 3245, 1614, 1584, 1484, 
1253, 757; 1H NMR (400MHz, CDCl3); 8.03 (1H, d, J = 8.0 Hz, ArH), 7.94 (1H, s, H-5’’), 7.37 (1H, d, J = 8.0 
Hz, ArH), 7.33 (1H, t, J = 7.0 Hz, ArH), 7.26 -7.23 (1H, m, ArH), 7.08 (1H, s H-7), 6.90 (1H, d, J = 9.0 Hz, H-
5), 6.42 (1H, d, J = 9.0 Hz), 4.86 (2H, d, J = 5.5 Hz, H-1’), 4.46 (2H, d, J = 6.0 Hz, H-2’); 13C NMR (100MHz, 
CDCl3); 42.6 (C-2’), 45.9 (C-1’), 107.7 (C-4), 114.2 (C-7), 118.8 (C-4), 120.6 (ArC), 122.2 (ArC), 123.3 (C-
5’’), 126.1 (ArCH), 127.8 (ArC), 128.1 (ArCH), 128.8 (ArCH), 129.0 (ArCH), 130.2 (ArC), 137.6 (ArC), 142.8 
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Using the general procedure; to a solution of azide 6 (0.17 g, 0.55 mmol, 1.0 equiv.) and 1-bromo-4-
ethynylbenzene (0.15 g, 0.82 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.6 mL 1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
bromophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5w, 0.18 g, 0.38 mmol, 69 %) 
as an off-white solid; Rf 0.17 (100 % EtOAc), m.p. 213 - 215 °C; IR νmax/cm-1 3240, 3087, 1614, 1584, 1484, 
1254, 757; 1H NMR (400MHz, CDCl3); 7.61 (1H, s, H-5’’), 7.54 - 7.49 (4H, m, ArH), 7.10 (1H, d, J = 1.5 Hz, 
H-7), 6.94 (1H, dd, J = 1.5 Hz and 9.0 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.82 (2H, t, J = 6.0 Hz, H-1’), 
4.46 (2H, t, J = 6.0 Hz, H-1’); 13C NMR (100MHz, CDCl3); 43.5 (C-1’), 46.9 (C-2’), 108.9 (C-4), 115.3 (C-7), 
119.8 (C-5), 120.9 (C-5’’), 122.2 (ArC), 123.2 (ArC), 127.2 (ArCH), 129.1 (ArC), 132.0 (ArCH), 138.5 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.16 g, 0.53 mmol, 1.0 equiv.) and 1-bromo-2-
ethynylbenzene (0.1 mL, 0.80 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.5 mL 1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
left to stir at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-
(2-bromophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5x, 0.13 g, 0.26 mmol, 50 
%) as a pale yellow solid; Rf 0.25 (100 % EtOAc), m.p. 169 - 174 °C; IR νmax/cm-1 3254, 3083, 1616, 1585, 
1484, 1234; 1H NMR (400MHz, CDCl3); 7.97 (1H, s, H-5’’), 7.87 (1H, dd, J = 1.5 Hz and 8.0 Hz, ArH), 7.57 
(1H, dd, J = 1.0 Hz and 8.0 Hz, ArH), 7.36 (1H, td, J = 1.0 Hz and 7.5 Hz, ArH), 7.17 (1H, td, J = 1.5 Hz and 
8.0 Hz, ArH), 7.08 (1H, d, J = 1.5 Hz, H-7), 6.90 (1H, dd, J = 1.5 Hz and 9.0 Hz, H-5), 6.41 (1H, d, J = 9.0 
Hz, H-4), 4.87 (2H, t, J = 5.5 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.8 (C-2’), 
47.1 (C-1’), 108.8 (C-4), 115.3 (C-7), 119.9 (C-5), 121.2 (ArC), 123.2 (ArC), 124.2 (C-5’’), 127.6 (ArCH), 
129.5 (ArCH), 130.5 (ArCH), 133.4 (ArCH), 138.6 (ArC), 145.7 (ArC); MS m/z [M+H]+ C18H14BrF3N5OS 
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Using the general procedure; to a solution of azide 6 (0.28 g, 0.93 mmol, 1.0 equiv.) and 1-ethynyl-2-
fluorobenzene (0.2 mL, 1.39 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.9 mL 1M CuSO4 (aq) and 1.9 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(2-
fluorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5y, 0.21 g, 0.49 mmol, 52 %) 
as an off-white solid; Rf 0.33 (100 % EtOAc), m.p. 172 - 175 °C; IR νmax/cm-1 3243, 3068, 2958, 1576, 1483, 
1254; 1H NMR (400MHz, CDCl3); 8.17 (1H, td, J = 1.5 Hz and 7.5 Hz, ArH), 7.77 (1H, d, J = 3.5 Hz, H-5’’), 
7.31 - 7.28 (1H, m, ArH), 7.22 (1H, t, J = 7.5 Hz, ArH), 7.09 - 7.00 (3H, m, ArH, Ar(NH), and H-7), 6.91 (1H, 
d, J = 8.5 Hz, H-5), 6.50 (1H, d, J = 9.0 Hz, H-4), 4.84 (2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’); 
13C NMR (100MHz, CDCl3); 42.5 (C-2’), 45.8 (C-1’), 107.8 (C-4), 114.2 (C-7), 114.5 (ArCH), 117.1 (ArC), 
118.7 (C-5), 122.2 (ArC), 122.8 (C-5’’), 123.5 (ArCH), 126.7 (ArCH), 128.4 (ArCH), 137.5 (ArC), 140.4 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.21 g, 0.70 mmol, 1.0 equiv.) and 1-ethynyl-4-
fluorobenzene (0.1 mL, 1.05 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.7 mL 1M CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
fluorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5z, 0.16 g, 0.39 mmol, 56 %) 
as an off-white solid; Rf 0.15 (100 % EtOAc), m.p. 193 - 197 °C; IR νmax/cm-1 3230, 3014, 1601, 1582, 1484, 
1261; 1H NMR (400MHz, CDCl3); 7.61 (2H, dd, J = 5.5 Hz and 8.5 Hz, ArH), 7.56 (1H, s, H-5’’), 7.09 (1H, s, 
H-7), 7.06 (2H, appt, J = 8.5 Hz, ArH), 6.93 (1H, d, J = 8.5 Hz, H-5), 6.52 (1H, d, J = 9.0 Hz, H-4), 4.81 (2H, 
t, J = 6.0 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.5 (C-2’), 45.9 (C-1’), 107.9 
(C-4), 114.2 (C-7), 114.7 (ArCH), 114.9 (ArCH), 118.8 (C-5), 119.5 (C-5’’), 122.2 (ArC), 126.4 (ArC), 126.5 
(ArC), 137.5 (ArC), 142.8 (Ar(OCF3)), 146.3 (ArC), 159.8 (ArC), 162.9 (ArC); MS m/z [M+H]+ C18H14F4N5OS 
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Using the general procedure; to a solution of azide 6 (0.26 g, 0.84 mmol, 1.0 equiv.) and 1-ethynyl-3-
fluorobenzene (0.2 mL, 1.27 mmol, 1.5 equiv.) in 15.0 mL H2O and 15.0 mL THF heated to 20 °C was added 
0.8 mL 1M CuSO4 (aq) and 1.7 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(3-
fluorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5aa, 0.16 g, 0.37 mmol, 44 %) 
as an off-white solid; Rf 0.19 (100 % EtOAc), m.p. 185 - 190 °C; IR νmax/cm-1 3242, 3079, 2953, 1614, 1583, 
1482, 1257; 1H NMR (400MHz, CDCl3); 7.61 (1H, s, H-5’’), 7.40 (2H, appt, J = 7.5 Hz, ArH), 7.34 (1H, appq, 
J = 8.0 Hz, ArH), 7.09 (1H, s, H-7), 7.01 (1H, t, J = 8.5 Hz, ArH), 6.94 (1H, d, J = 9.5 Hz, H-5), 6.52 (1H, d, J 
= 9.0 Hz, H-4), 4.82 (2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.5 
(C-2’), 47.0 (C-1’), 108.9 (C-4), 112.6 (ArC), 112.8 (ArCH), 115.0 (ArCH), 115.2 (ArC), 115.3 (C-7), 119.9 (C-
5), 121.1 (C-5’’), 121.3 (ArCH), 123.2 (ArC), 130.4 (ArCH), 132.2 (ArC), 138.5 (ArC), 143.9 (Ar(OCF3)), 147.1 
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Using the general procedure; to a solution of azide 6 (0.31 g, 1.02 mmol, 1.0 equiv.) and 1-ethynyl-2,4-
difluorobenzene (0.2 mL, 1.53 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 1.0 mL 1M CuSO4 (aq) and 2.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  The crude was column purified using 100 % EtOAc to yield 3-(2-(4-(2,4-
difluorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ab, 0.22 g, 0.51 mmol, 50 
%) as an off-white solid; Rf 0.33 (100 % EtOAc), m.p. 194 - 200 °C; IR νmax/cm-1 3234, 3028, 1578, 1483, 
1257; 1H NMR (400MHz, CDCl3); 8.16 (1H, td, J = 5.0 Hz and 9.0 Hz, ArH), 7.71 (1H, d, J = 3.5 Hz, H-5’’), 
7.09 (1H, s, H-7), 6.97 (1H, td, J = 3.0 Hz and 9.0 Hz, ArH), 6.91 (1H, d, J = 7.0 Hz, H-5), 6.83 (1H, ddd, J = 
2.5 Hz, 9.0 Hz and 11.0 Hz, ArH), 6.49 (1H, d, J = 9.0 Hz, H-4), 4.83 (2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 
6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.5 (C-2’), 46.9 (C-1’), 103.8 (ArC), 104.0 (ArCH), 104.3 (ArC), 
108.8 (C-4), 111.9 (ArCH), 112.1 (ArC), 114.6 (ArC), 115.3 (C-7), 119.1 (ArC), 119.8 (C-5), 123.3 (C-5’’), 
123.4 (ArC), 128.8 (ArCH), 138.5 (ArC), 140.8 (ArC), 143.8 (Ar(OCF3)); MS m/z [M+H]+ C18H13F5N5OS 
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Using the general procedure; to a solution of azide 6 (0.15 g, 0.51 mmol, 1.0 equiv.) and 3,4-
difluorophenylacetylene (0.1 mL, 0.76 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C 
was added 0.5 mL 1M CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This 
was stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-
(3,4-difluorophenyl)-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ac, 0.10 g, 0.23 
mmol, 44 %) as an off-white solid; Rf  0.17 (100 % EtOAc), m.p. 179 - 184 °C; IR νmax/cm-1 3227, 3043, 
1580, 1483, 1266; 1H NMR (400MHz, CDCl3); 7.57 (1H, s, H-5’’), 7.50 (1H, dddd, J = 2.0 Hz, 7.5 Hz and 10.0 
Hz, ArH), 7.36 - 7.33 (1H, m, ArH), 7.16 (1H, q, J = 8.5 Hz, ArH), 7.10 (1H, s, H-7), 6.94 (1H, d, J = 8.5 Hz, 
H-5), 6.51 (1H, d, J = 9.0 Hz, H-4), 4.82 (2H, t, J = 6.0 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR 
(100MHz, CDCl3); 42.4 (C-2’), 45.9 (C-1’), 107.8 (C-4), 113.9 (ArC), 114.3 (ArCH), 116.6 (C-7), 116.7 
(ArCH), 118.8 (C-5), 119.9 (C-5’’), 120.7 (ArC), 122.2 (ArCH), 126.2 (ArC), 137.5 (ArC), 142.8 (Ar(OCF3)), 
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Using the general procedure; to a solution of azide 6 (0.19 g, 0.61 mmol, 1.0 equiv.) and 1-ethynyl-3,5-
difluorobenzene (0.1 mL, 0.92 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.6 mL CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(2,4-
difluorophenyl)-1,2,3-triazol-1-ly)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ad, 0.11 g, 0.25 mmol, 41 
%) as an off-white solid; Rf  0.23 (100 % EtOAc), m.p. 183 - 185 °C; IR νmax/cm-1 3259, 3087, 1617, 1588, 
1484, 1262; 1H NMR (400MHz, CDCl3); 7.62 (1H, s, H-5’’), 7.19 (2H, d, J = 6.5 Hz, ArH), 7.10 (1H, s, H-7), 
6.94 (1H, d, J = 8.5 Hz, H-5), 6.75 (1H, tt, J = 2.0 Hz and 9.0 Hz, ArH), 6.51 (1H, d, J = 9.0 Hz, H-4), 4.83 
(2H, t, J = 6.0 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.4 (C-2’), 46.0 (C-1’), 
102.5 (ArCH), 107.4 (ArCH), 107.6 (ArC), 107.8 (C-4), 114.3 (C-7), 118.8 (C-5), 120.4 (C-5’’), 122.2 (ArC), 
132.1 (ArC), 137.4 (ArC), 142.8 (Ar(OCF3)), 145.1 (ArC), 161.1 (ArC), 163.5 (ArC); MS m/z [M+H]+ 
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Using the general procedure; to a solution of azide 6 (0.14 g, 0.46 mmol, 1.0 equiv.) and 3,4,5-
trifluorophenylacetylene (0.11 g, 0.69 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C 
was added 0.5 mL 1M CuSO4 (aq) and 0.9 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This 
was stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 6-
(trifluoromethoxy)-3-(2-(4-(3,4,5-trifluorophenyl)-1,2,3-triazol-1yl)ethyl)benzothiazol-2-imine (5ae, 0.16 g, 
0.34 mmol, 74 %) as a pale yellow solid; Rf 0.21 (100 % EtOAc), m.p. 166 - 170 °C; IR νmax/cm-1 3229, 3077, 
1607, 1518, 1483, 1257; 1H NMR (400MHz, CDCl3); 7.59 (1H, s, H-5’’), 7.32 - 7.24 (2H, m, ArH), 7.11 (1H, d, 
J = 1.5 Hz, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.51 (1H, d, J = 9.0 Hz, H-4), 4.82 (2H, t, J = 6.0 Hz, H-1’), 
4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.4 (C-2’), 47.0 (C-1’), 108.8 (C-4), 109.7 (ArCH), 
109.9 (ArCH), 115.4 (C-7), 119.9 (C-5), 121.2 (C-5’’), 123.2 (ArC), 138.6 (ArC); MS m/z [M+H]+ 
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Using the general procedure; to a solution of azide 6 (0.18 g, 0.59 mmol, 1.0 equiv.) and 3-ethynyl-α,α,α-
trifluorotoluene (0.1 mL, 0.88 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.6 mL 1M CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 6-
(trifluoromethoxy)-3-(2-(4-(3-(trifluoromethyl)phenyl)-1,2,3-triazol-1-yl)ethyl)benzothiazol-2-imine (5af, 0.18 g, 
0.39 mmol, 66 %) as a yellow/green solid; Rf 0.21 (100 % EtOAc), m.p. 145 - 149 °C; IR νmax/cm-1 3246, 
3071, 1578, 1483, 1322, 1253; 1H NMR (400MHz, CDCl3); 7.91 (1H, s, ArH), 7.85 (1H, d, J = 7.5 Hz, ArH), 
7.70 (1H, s, H-5’’), 7.57 (1H, d, J = 8.0 Hz, ArH), 7.50 (1H, t, J = 7.5 Hz, ArH), 7.10 (1H, s, H-7), 6.94 (1H, d, 
J = 8.0 Hz, H-5), 6.54 (1H, d, J = 9.0 Hz, H-4), 4.84 (2H, bs, H-1’), 4.48 (2H, bs, H-2’); 13C NMR (100MHz, 
CDCl3); 42.4 (C-2’), 45.9 (C-1’), 107.8 (C-4), 114.3 (C-7), 118.8 (C-5), 120.3 (C-5’’), 120.6 (ArC), 121.4 
(ArCH), 121.6 (ArC), 122.2 (Ar(CF3), 123.8 (ArCH), 124.3 (ArC), 127.8 (ArCH), 128.3 (ArCH), 130.1 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.22 g, 0.74 mmol, 1.0 equiv.) and 2-ethynyl-α,α,α-
trifluorotoluene (0.2 mL, 1.11 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.7 mL 1M CuSO4 (aq) and 1.5 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 6-
(trifluoromethoxy)-3-(2-(4-(2-(trifluoromethyl)phenyl)-1,2,3-triazol-1-yl)ethyl)benzothiazol-2-imine (5ag, 0.21 
g, 0.43 mmol, 59 %) as an off white solid; Rf 0.32 (100 % EtOAc), m.p. 186 - 190 °C; IR νmax/cm-1 3245, 
3081, 1616, 1585, 1485, 1318, 1256; 1H NMR (400MHz, CDCl3); 7.69 (2H, t, J = 7.5 Hz, ArH), 7.57 (2H, t, J 
= 9.5 Hz, ArH and H-5’’), 7.45 (1H, t, J = 7.5 Hz, ArH), 7.08 (1H, s, H-7), 6.93 (1H, d, J = 9.0 Hz, H-5), 6.45 
(1H, d, J = 9.0 Hz, H-4), 4.87 (2H, t, J = 5.5 Hz, H-1’), 4.47 (2H, t, J = 5.5 Hz, H-2’); 13C NMR (100MHz, 
CDCl3); 42.8 (C-2’), 46.0 (C-1’), 107.7 (C-4), 114.2 (C-7), 118.7 (C-4), 122.2 (ArC), 123.0 (Ar(CF3)), 124.2 
(C-5’’), 125.0 (ArC), 126.2 (ArCH), 126.5 (ArC), 127.3 (ArC), 128.0 (ArCH), 130.6 (ArCH), 130.9 (ArCH), 
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Using the general procedure; to a solution of azide 6 (0.22 g, 0.72 mmol, 1.0 equiv.) and 4-ethynyl-α,α,α-
trifluorotoluene (0.2 mL, 1.09 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.7 mL 1M CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 6-
(trifluoromethoxy)-3-(2-(4-(4-(trifluoromethyl)phenyl)-1,2,3-triazol-1-yl)ethyl)benzothiazol-2-imine (5ah, 0.12 
g, 0.25 mmol, 35 %) as a pale yellow solid; Rf 0.17 (100 % EtOAc), m.p. 218 - 221 °C; IR νmax/cm-1 3253, 
3021, 1613, 1584, 1484, 1326, 1234; 1H NMR (400MHz, CDCl3); 7.78 (2H, d, J = 8.0 Hz, ArH), 7.69 (1H, s, 
H-5’’), 7.63 (2H, d, J = 8.0 Hz, ArH), 7.10 (1H, d, J = 1.5 Hz, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, 
J = 9.0 Hz, H-4), 4.84 (2H, t, J = 5.5 Hz, H-1’), 4.48 (2H, t, J = 5.5 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.5 
(C-2’), 47.0 (C-1’), 108.9 (C-4), 115.5 (C-7), 119.9 (C-5), 121.6 (C-5’’), 122.7 (ArC), 123.3 (Ar(CF3)), 123.7 
(ArC), 125.8 (ArCH), 129.7 (ArC), 130.0 (ArC), 130.3 (ArC), 133.6 (ArC), 138.6 (Ar(OCF3)), 143.9 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.14 g, 0.47 mmol, 1.0 equiv.) and 1-ethynyl-3,5-
bis(trifluoromethyl) benzene (0.1 mL, 0.71 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 
°C was added 0.5 mL 1M CuSO4 (aq) and 0.9 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  
This was stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 6-
(trifluoromethyoxy)-3-(2-(4-(3,5-bis(trifluoromethyl)phenyl)-1,2,3-triazol-1-ly)ethyl)benzothiazol-2-imine (5ai, 
0.22 g, 0.41 mmol, 87 %) as a pale yellow solid; Rf 0.31 (100 % EtOAc), m.p. 184 - 188 °C; IR νmax/cm-1 
3217, 3043, 1624, 1587, 1484, 1324, 1275; 1H NMR (400MHz, CDCl3); 8.12 (2H, s, ArH), 7.81 (1H, s, ArH), 
7.79 (1H, s, H-5’’), 7.10 (1H, d, J = 1.5 Hz, H-7), 6.95 (1H, d, J = 8.5 Hz, H-5), 6.55 (1H, d, J = 9.0 Hz, H-4), 
4.87 (2H, t, J = 6.0 Hz, H-1’), 4.49 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 43.3 (C-2’), 47.1 (C-
1’), 108.8 (C-4), 115.4 (C-7), 119.9 (C-5), 121.8 (C-5’’), 121.9 (ArCH), 123.3 (ArC), 124.5 (ArC), 125.6 
(ArCH), 132.1 (ArC), 132.2 (ArC), 132.5 (ArC), 143.9 (ArC), 145.4 (ArC); MS m/z [M+H]+ C20H13F9N5OS 
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 Methyl 4-(1-(2-(2-imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)benzoate 5aj 
 
Using the general procedure; to a solution of azide 6 (0.14 g, 0.45 mmol, 1.0 equiv.) and methyl-4-
ethynylbenzoate (0.11 g, 0.67 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.5 mL 1M CuSO4 (aq) and 0.9 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield methyl 4-(1-
(2-(2-imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)benzoate (5aj, 0.12 g, 0.26 mmol, 
59 %) as an off white solid; Rf 0.19 (100 % EtOAc), m.p. 196 - 199 °C; IR νmax/cm-1 3276, 3099, 1721, 1604, 
1582, 1485, 1261; 1H NMR (400MHz, CDCl3); 8.05 (2H, d, J = 8.5 Hz, ArH), 7.74 (2H, d, J = 8.5 Hz, ArH), 
7.71 (1H, s, H-5’), 7.10 (1H, d, J = 1.5 Hz, H-7’’’), 6.94 (1H, d, J = 8.5 Hz, H-5’’’), 6.55 (1H, d, J = 9.0 Hz, H-
4’’’), 4.84 (2H, t, J = 6.0 Hz, H-1’’), 4.48 (2H, t, J = 6.0 Hz, H-2’’), 3.93 (3H, s, O(CH3)); 13C NMR (100MHz, 
CDCl3); 43.6 (C-2’’), 47.0 (C-1’’), 52.2 (O(CH3)), 108.9 (C-4’’’), 115.3 (C-7’’’), 119.8 (C-5’’’), 121.6 (C-5’), 
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 4-(1-(2-(2-Imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)benzoic acid 5ak 
 
Using the general procedure; to a solution of azide 6 (0.16 g, 0.53 mmol, 1.0 equiv.) and 4-ethynylbenzoic 
acid (0.12 g, 0.79 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M 
CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  Once washed with brine a precipitate formed.  This was filtered to yield 4-(1-(2-(2-imino-6-
(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl)benzoic acid (5ak, 0.14 g, 0.31 mmol, 59 %) as 
an off-white solid; m.p. 380 - 384 °C; IR νmax/cm-1 3238, 1585, 1484, 1262; 1H NMR (500MHz, MeOD); 8.32 
(1H, s, H-5’), 8.00 (2H, d, J = 10.0 Hz, ArH), 7.71 (2H, d, J = 5.0 Hz, ArH), 7.33 (1H, s, H-7’’’), 6.99 (1H, d, J 
= 10.0 Hz, H-5’’’), 6.77 (1H, d, J = 10.0 Hz, H-4’’’), 4.88 (2H, t, J = 5.0 Hz, H-1’’), 4.52 (2H, t, J = 5.0 Hz, H-
2’’); 13C NMR (125MHz, MeOD); 42.6 (C-2’’), 46.7 (C-1’’), 109.3 (C-4’’’), 115.2 (C-7’’’), 119.0 (C-5’’’), 122.4 
(C-5’), 124.7 (ArCH), 129.5 (ArCH), 132.1 (ArC), 138.8 (ArC), 143.9 (ArC), 147.5 (ArC); MS m/z [M+H]+ 
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Using the general procedure; to a solution of azide 6 (0.15 g, 0.48 mmol, 1.0 equiv.) and 1-ethynyl-4-
nitrobenzene (0.11 g, 0.72 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.5 mL 1M CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(4-
nitrophenyl)-1,2,3-triazol-1-yl)ethyl)-6-trifluoromethoxy)benzothiazol-2-imine (5al, 0.14 g, 0.30 mmol, 63 %) 
as a pale yellow solid; Rf 0.15 (100 % EtOAc), m.p. 181 - 186 °C; IR νmax/cm-1 3322, 3077, 1605, 1581, 
1514, 1484, 1331, 1257; 1H NMR (400MHz, CDCl3); 8.25 (2H, d, J = 8.5 Hz, ArH), 7.84 (2H, d, J = 8.5 Hz, 
ArH), 7.77 (1H, s, H-5’’), 7.10 (1H, s, H-7), 6.94 (1H, d, J = 9.0 Hz, H-5), 6.55 (1H, d, J = 9.0 Hz, H-4), 4.86 
(2H, t, J = 6.0 Hz, H-1’), 4.49 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.3 (C-2’), 46.0 (C-1’), 
107.8 (C-4), 114.5 (C-7), 118.8 (C-5), 120.6 (ArC), 121.3 (C-5’’), 122.3 (ArC), 123.2 (ArCH), 125.1 (ArC), 
135.4 (ArC), 137.4 (ArC), 142.8 (Ar(OCF3)), 144.8 (ArC), 146.3 (ArC), 159.7 (ArC); MS m/z [M+H]+ 
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4-(1-(2-(2-Imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl) benzonitrile 5am 
 
Using the general procedure; to a solution of azide 6 (0.21 g, 0.70 mmol, 1.0 equiv.) and 4-
ethynylbenzonitrile (0.13 g, 1.05 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.7 mL 1M CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 4-(1-(2-(2-
imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazol-4-yl) benzonitrile4 (5am, 0.18 g, 0.32 mmol, 
59 %) as an off-white solid; Rf 0.12 (100 % EtOAc), m.p. 193 - 198 °C; IR νmax/cm-1 3320, 3048, 2222, 1612, 
1584, 1483, 1252; 1H NMR (400MHz, CDCl3); 7.77 (2H, d, J = 8.0 Hz, ArH), 7.71 (1H, s, H-5’), 7.67 (2H, d, J 
= 8.0 Hz, ArH), 7.10 (1H, s, H-7’’’), 6.93 (1H, d, J = 8.5 Hz, H-5’’’), 6.53 (1H, d, J = 9.0 Hz, H-4’’’), 4.85 (2H, t, 
J = 6.0 Hz, H-1’’), 4.48 (2H, t, J = 6.0 Hz, H-2’’); 13C NMR (100MHz, CDCl3) 43.4 (C-2’’), 47.0 (C-1’’), 108.8 
(C-4’’’), 111.7 (ArC), 115.4 (C-7’’’), 118.7 (Ar(CN)), 119.1 (ArC), 119.9 (C-5’’’), 121.9 (C-5’), 123.3 (ArC), 
126.1 (ArCH), 132.7 (ArCH), 134.5 (ArC), 138.5 (ArC), 143.8 (Ar(OCF3)), 146.3 (ArC), 160.8 (ArC); MS m/z 
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Using the general procedure; to a solution of azide 6 (0.16 g, 0.51 mmol, 1.0 equiv.) and 3-ethynylpyridine 
(0.08 g, 0.77 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M 
CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2.5 h.  After work-up the crude was column purified using a gradient solvent system from 100 % EtOAc to 
100 % MeOH to yield 3-(2-(4-(pyridin-3-yl)-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 
(5an, 0.13 g, 0.32 mmol, 64 %) as a pale yellow solid; Rf 0.08 (100 % EtOAc), m.p. 195 - 197 °C; IR νmax/cm-
1 3217, 3035, 1618, 1585, 1482, 1262; 1H NMR (400MHz, CDCl3); 8.82 (1H, s, CH(Py.)), 8.56 (1H, d, J = 4.0 
Hz, CH(Py.)), 8.04 (1H, d, J = 8.0 Hz, CH(Py.)), 7.69 (1H, s, H-5’’), 7.33 (1H, q, J = 5.0 Hz, CH(Py.)), 7.09 
(1H, s, H-7), 6.94 (1H, d, J = 8.5 Hz, H-5), 6.53 (1H, d, J = 9.0 Hz, H-4), 4.84 (2H, t, J = 6.0 Hz, H-1’), 4.48 
(2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.4 (C-2’), 45.9 (C-1’), 107.8 (C-4), 114.3 (C-7), 118.8 
(C-5), 120.1 (C-5’’), 120.6 (ArC), 122.2 (ArC), 122.7 (ArC), 125.3 (CH(Py.)), 132.0 (CH(Py.)), 137.4 (ArC), 
142.8 (Ar(OCF3)), 144.0 (ArC), 145.9 (CH(Py.)), 148.3 (CH(Py.)), 159.8 (ArC); MS m/z [M+H]+ C17H14F3N6OS 
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Using the general procedure; to a solution of azide 6 (0.25 g, 0.82 mmol, 1.0 equiv.) and 4-ethynylpyridine 
(0.17 g, 1.23 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.8 mL 1M 
CuSO4 (aq) and 1.6 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 9:1 DCM:MeOH to yield 3-(2-(4-(pyridin-4-yl)-1,2,3-
triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ao, 0.15 g, 0.38 mmol, 46 %) as an off white 
solid; Rf 0.21 (9:1 DCM:MeOH), m.p. 209 - 211 °C; IR νmax/cm-1 3221, 3028, 1604, 1583, 1482, 1266; 1H 
NMR (400MHz, CDCl3); 8.63 (2H, bs, CH(Py.)), 7.77 (1H, s, H-5’’), 7.57 (2H, d, J = 5.0 Hz, CH(Py.)), 7.10 
(1H, s, H-7), 6.91 (1H, d, J = 9.0 Hz, H-5), 6.54 (1H, d, J = 9.0 Hz, H-4), 4.85 (2H, t, J = 6.0 Hz, H-1’), 4.48 
(2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.4 (C-2’), 46.0 (C-1’), 107.8 (C-4), 114.3 (C-7), 118.0 
(ArC), 118.8 (C-5), 120.6 (ArC), 121.2 (CH(Py.)), 122.2 (C-5’’), 136.4 (ArC), 137.4 (ArC), 142.8 (Ar(OCF3)), 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.67 mmol, 1.0 equiv.) and 2-ethynylpyridine 
(0.1 mL, 1.01 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using a gradient solvent system from 100 % EtOAc to 100 
% MeOH to yield 3-(2-(4-(pyridin-2-yl)-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ap, 
0.15 g, 0.36 mmol, 53 %) a pale yellow solid; Rf 0.07 (100 % EtOAc), m.p. 156 - 160 °C; IR νmax/cm-1 3206, 
3056, 1602, 1581, 1484, 1260; 1H NMR (400MHz, CDCl3); 8.52 (1H, d, J = 4.5 Hz, CH(Py.)), 8.08 (1H, d, J = 
8.0 Hz, CH(Py.)), 8.02 (1H, s, H-5’’), 7.75 (1H, t, J = 7.5 Hz, CH(Py.)), 7.21 (1H, t, J = 5.0 Hz, CH(Py.)), 7.11 
(1H, bs, NH), 7.07 (1H, s, H-7), 6.91 (1H, d, J = 9.0 Hz, H-5), 6.54 (1H, d, J = 9.0 Hz, H-4), 4.83 (2H, d, J = 
6.0 Hz, H-1’), 4.49 (2H, d, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.5 (C-2’), 46.0 (C-1’), 107.8 (C-4), 
114.3 (C-7), 119.1 (C-5), 121.9 (CH(Py.)), 122.2 (CH(Py.)), 122.4 (C-5’’), 135.8 (CH(Py.)), 137.6 (ArC), 142.7 
(Ar(OCF3)), 144.4 (ArC), 147.6 (ArC), 148.3 (CH(Py.)), 148.8 (ArC), 149.8 (ArC), 159.8 (ArC); MS m/z 
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Using the general procedure; to a solution of azide 6 (0.21 g, 0.70 mmol, 1.0 equiv.) and 2-ethynylthiophene 
(0.1 mL, 1.05 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(thiophen-2-yl)-1,2,3-
triazol-1-ly)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5aq, 0.15 g, 0.37 mmol, 53 %) as a pale yellow 
solid; Rf 0.19 (100 % EtOAc), m.p. 172 - 176 °C; IR νmax/cm-1 3245, 3068, 1605, 1583, 1483, 1256; 1H NMR 
(400MHz, CDCl3); 7.54 (1H, s, H-5’’), 7.28 - 7.26 (1H, m, ArH), 7.23 (1H, d, J = 3.0 Hz, ArH), 7.10 (1H, s, H-
7), 7.03 (1H, t, J = 4.0 Hz, ArH), 6.96 (1H, d, J = 8.5 Hz, H-5), 6.54 (1H, d, J = 9.0 Hz, H-4), 4.80 (2H, t, J = 
6.0 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.4 (C-2’), 45.9 (C-1’), 107.9 (C-4), 
114.2 (C-7), 118.8 (C-5), 119.3 (C-5’’), 120.6 (ArC), 122.2 (ArC), 123.3 (ArCH), 124.2 (ArCH), 126.5 (ArCH), 
131.3 (ArC), 137.5 (ArC), 142.0 (ArC), 142.8 (Ar(OCF3)), 159.8 (ArC); MS m/z [M+H]+ C16H13F3N5OS2 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.67 mmol, 1.0 equiv.) and 3-ethynylthiophene 
(0.1 mL, 1.00 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.7 mL 1M 
CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(thiophen-3-yl)-1,2,3-
triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ar, 0.15 g, 0.37 mmol, 55 %) as an off white 
solid; Rf 0.17 (100 % EtOAc), m.p. 185 - 188 °C; IR νmax/cm-1 3246, 3081, 1615, 1585, 1483, 1258; 1H NMR 
(400MHz, CDCl3); 7.55 (1H, d, J = 2.0 Hz, ArH), 7.53 (1H, s, H-5’’), 7.35 - 7.33 (1H, m, ArH), 7.30 (1H, d, J = 
5.0 Hz, ArH), 7.09 (1H, s, H-7), 6.95 (1H, d, J = 8.5 Hz, H-5), 6.55 (1H, d, J = 9.0 Hz, H-4), 4.80 (2H, t, J = 
6.0 Hz, H-1’), 4.46 (2H, t, J = 6.0 Hz, H-2’); 13C NMR (100MHz, CDCl3); 42.5 (C-2’), 45.8 (C-1’), 108.0 (C-4), 
114.2 (C-7), 118.8 (C-5), 119.6 (C-5’’), 120.2 (ArCH), 120.6 (ArC), 122.2 (ArC), 124.7 (ArCH), 125.3 (ArCH), 
130.3 (ArC), 137.5 (ArC), 142.8 (Ar(OCF3)), 143.2 (ArC), 159.8 (ArC); MS m/z [M+H]+ C16H13F3N5OS2 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.66 mmol, 1.0 equiv.) and 5-ethynyl-1-methyl-
1H-imidazole (0.1 mL, 0.99 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 
0.7 mL 1M CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred 
at 20 °C for 2 h.  After work-up the crude was column purified using 9:1 DCM:MeOH to yield 3-(2-(4-(1-
methyl-1H-imidazol-5-yl)-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5as, 0.18 g, 0.44 
mmol, 67 %) as an off white solid; Rf 0.52 (9:1 DCM:MeOH), m.p. 220 - 225 °C; IR νmax/cm-1 3161, 2958, 
1626, 1585, 1484, 1267; 1H NMR (400MHz, CDCl3); 7.52 (1H, s, H-5’’), 7.48 (1H, s, H-2’’’), 7.11 (1H, d, J 
=1.5 Hz, H-7), 7.06 (1H, s, H-5’’’), 6.94 (1H, dd, J = 1.5 Hz and 9.0 Hz, H-5), 6.51 (1H, d, J = 9.0 Hz, H-4), 
4.84 (2H, t, J = 5.5 Hz, H-1’), 4.47 (2H, t, J = 6.0 Hz, H-2’), 3.73 (3H, s, N(CH3)); 13C NMR (100MHz, CDCl3); 
33.2 (N(CH3)), 43.5 (C-2’), 46.8 (C-1’), 108.7 (C-4), 115.4 (C-7), 119.7 (C-5), 122.4 (C-5’’), 123.4 (ArC), 

























































































































PC                 1.50
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1300080 MHz
SI                32768
F2 − Processing parameters
PLW1        24.00000000 W
P1                 8.00 usec
NUC1                 1H
SFO1        400.1324710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           2.00000000 sec
TE                294.1 K
DE                10.69 usec
DW               60.800 usec
RG               147.88
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB/
INSTRUM           spect
Time              16.08
Date_          20140509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                30





Using the general procedure; to a solution of azide 6 (0.18 g, 0.59 mmol, 1.0 equiv.) and 4-phenyl-1-butyne 
(0.1 mL, 0.89 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.6 mL 1M 
CuSO4 (aq) and 1.2 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-phenylethyl-1,2,3-
triazolyl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5at, 0.12 g, 0.28 mmol, 47 %) as an off-white solid; 
Rf 0.13 (100 % EtOAc), m.p. 153 - 157 °C; IR νmax/cm-1 3263, 3030, 1614, 1585, 1484, 1260; 1H NMR 
(500MHz, CDCl3); 7.25 (2H, appt, J = 7.5 Hz, ArH), 7.19 (1H, t, J = 6.0 Hz, ArH), 7.11 (1H, s, H-7), 7.07 (2H, 
d, J = 7.0 Hz, ArH), 7.03 (1H, bs, NH), 6.96 - 6.94 (2H, m, H-5 and H-5’’), 6.39 (1H, d, J = 9.0 Hz, H-4), 4.69 
(2H, t, J = 5.5 Hz, H-1’), 4.39 (2H, t, J = 6.0 Hz, H-2’), 2.89 (2H, t, J = 7.5 Hz, H-2’’’), 2.77 (2H, t, J = 8.5 Hz, 
H-1’’’); 13C NMR (125MHz, CDCl3); 26.1 (C-2’’’), 34.4 (C-1’’’), 42.8 (C-2’), 45.8 (C-1’), 107.9 (C-4), 114.1 (C-
7), 118.1 (ArC), 118.8 (C-5), 122.1 (C-5’’), 123.2 (ArC), 125.1 (ArCH), 127.3 (ArCH), 127.4 (ArCH), 137.7 
(ArC), 140.0 (ArC), 142.7 (Ar(OCF3)) 146.6 (ArC), 159.67 (ArC); MS m/z [M+H]+ C20H19F3N5OS requires 
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Using the general procedure; to a solution of azide 6 (0.14 g, 0.48 mmol, 1.0 equiv.) and 4-methyl-1-pentyne 
(0.1 mL, 0.72 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M 
CuSO4 (aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-isobutyl-1,2,3-triazol-1-
yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5au, 0.18 g, 0.47 mmol, 98 %) as an off-white solid; Rf 
0.19 (100 % EtOAc), m.p. 165 -170 °C; IR νmax/cm-1 3237, 3065, 2955, 1580, 1485, 1263; 1H NMR (400MHz, 
CDCl3); 7.07 (2H, s, H-7 and H-5’’), 6.91 (1H, dd, J = 1.5 Hz and 9.0 Hz, H-5), 6.38 (1H, d, J = 9.0 Hz, H-4), 
4.76 (2H, t, J = 5.5 Hz, H-1’), 4.40 (1H, t, J = 6.0 Hz, H-2’), 2.42 (2H, d, J = 6.0 Hz, H-1’’’), 1.70 (1H, sept, J = 
6.5 Hz, H-2’’’), 0.72 (6H, d, J = 6.5 Hz, H-3’’’ and H-1’’’’); 13C NMR (100MHz, CDCl3); 21.9 (C-1’’’’ and C-3’’’), 
28.5 (C-2’’’), 34.4 (C-1’’’), 44.0 (C-2’), 46.7 (C-1’), 108.9 (C-4), 115.1 (C-7), 119.8 (C-5), 122.5 (C-5’’); MS 
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Using the general procedure; to a solution of azide 6 (0.16 g, 0.53 mmol, 1.0 equiv.) and 3,3-dimethyl-1-
butyne (0.1 mL, 0.80 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 
1M CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 
°C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-(tert-butyl)-1,2,3-
triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5av, 0.13 g, 0.34 mmol, 64 %) as a pale yellow 
solid; Rf 0.13 (100 % EtOAc), m.p. 150 - 154 °C; IR νmax/cm-1 3256, 3068, 2979, 1605, 1580, 1484, 1258; 1H 
NMR (400MHz, CDCl3); 7.09 (1H, s, H-7), 6.98 (1H, s, H-5’’), 6.89 (1H, d, J = 9.0 Hz, H-5), 6.25 (1H, d, J = 
9.0 Hz, H-4), 4.74 (2H, t, J = 5.5 Hz, H-1’), 4.36 (2H, t, J = 5.5 Hz, H-2’), 1.12 (9H, s, ArC(CH3)3); 13C NMR 
(100MHz, CDCl3); 29.1 (ArC(CH3)3), 42.9 (C-2’), 45.6 (C-1’), 107.7 (C-4), 114.0 (C-7), 118.1 (ArC), 118.7 (C-
5), 118.8 (C-5’’), 120.7 (ArC), 123.2 (ArC), 137.7 (ArC), 142.6 (Ar(OCF3)), 157.1 (ArC), 159.6 (ArC); MS m/z 
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Using the general procedure; to a solution of azide 6 (0.16 g, 0.53 mmol, 1.0 equiv.) and 1-pentyne (0.1 mL, 
0.79 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M CuSO4 (aq) 
and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 2 h.  After 
work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-propyl-1,2,3-triazol-1-yl)ethyl)-6-
(trifluoromethoxy)benzothiazol-2-imine (5aw, 0.09 g, 0.23 mmol, 44 %) as a pale yellow solid; Rf 0.14 (100 % 
EtOAc), m.p. 134 - 138 °C; IR νmax/cm-1 3334, 3072, 2961, 2933, 1602, 1580, 1484, 1257; 1H NMR 
(400MHz, CDCl3); 7.09 (1H, d, J = 1.5 Hz, H-7), 7.06 (1H, s, H-5’’), 6.92 (1H, dd, J = 1.5 Hz and 9.0 Hz, H-5), 
6.35 (1H, d, J = 9.0 Hz, H-4), 4.74 (2H, t, J = 5.5 Hz, H-1’), 4.39 (2H, t, J = 6.0 Hz, H-2’), 2.52 (2H, t, J = 7.5 
Hz, H-1’’’), 1.44 (2H, sext, J = 7.5 Hz, H-2’’’), 0.78 (3H, t, J = 7.5 Hz, H-3’’’); 13C NMR (100MHz, CDCl3); 13.4 
(C-3’’’), 22.7 (C-2’’’), 27.3 (C-1’’’), 43.9 (C-2’), 46.7 (C-1’), 108.8 (C-4), 115.1 (C-7), 119.8 (C-5), 121.9 (C-5’’), 
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Using the general procedure; to a solution of azide 6 (0.16 g, 0.54 mmol, 1.0 equiv.) and 5-methyl-1-hexyne 
(0.1 mL, 0.81 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M 
CuSO4 (aq) and 1.1 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-isopentyl-1,2,3-triazol-
1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ax, 0.14 g, 0.34 mmol, 63 %) as a pale yellow solid; Rf 
0.11 (100 % EtOAc), m.p. 126 - 129 °C; IR νmax/cm-1 3232, 3072, 2958, 1602, 1581, 1484, 1257; 1H NMR 
(400MHz, CDCl3); 7.09 (1H, s, H-7), 7.07 (1H, s, H-5’’), 6.92 (1H, d, J = 9.0 Hz, H-5), 6.36 (1H, d, J = 9.0 Hz, 
H-4), 4.73 (2H, t, J = 5.5 Hz, H-1’), 4.39 (2H, t, J = 6.0 Hz, H-2’), 2.54 (2H, t, J = 8.0 Hz, H-1’’’), 1.46 - 1.36 
(1H, m, H-3’’’), 1.34 - 1.28 (2H, m, H-2’’’). 0.85 (6H, d, J = 6.5 Hz, H-4’’’ and H-1’’’’); 13C NMR (100MHz, 
CDCl3); 22.2 (C-4’’’ and C-1’’’’), 26.3 (C-1’’’), 37.4 (C-2’’’ and C-3’’’), 42.8 (C-2’), 45.7 (C-1’), 107.9 (C-4), 
114.0 (C-7), 118.1 (ArC), 118.7 (C-5), 120.7 (C-5’’), 122.1 (ArC), 137.6 (ArC), 142.7 (Ar(OCF3)), 147.9 (ArC), 
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Using the general procedure; to a solution of azide 6 (0.20 g, 0.66 mmol, 1.0 equiv.) and 
cyclopropylacetylene (0.1 mL, 0.99 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.7 mL 1M CuSO4 (aq) and 1.3 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-
cyclopropyl-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5ay, 0.16 g, 0.44 mmol, 67 %) 
as a pale yellow solid; Rf 0.10 (100 % EtOAc), m.p. 149 - 152 °C; IR νmax/cm-1 3220, 3089, 2950, 1601, 
1580, 1484, 1256; 1H NMR (400MHz, CDCl3); 7.10 (1H, s, H-7), 7.01 (1H, s, H-5’’), 6.93 (1H, d, J = 9.0 Hz, 
H-5), 6.33 (1H, d, J = 9.0 Hz, H-4), 4.70 (2H, t, J = 5.5 Hz, H-1’), 4.37 (2H, t, J = 6.0 Hz, H-2’), 1.78 (1H, tt, J 
= 5.0 Hz and 13.5 Hz, H-1’’’), 0.83 (2H, dt, J = 4.5 Hz and 15.0 Hz, H-2’’’ and H-3’’’), 0.57 (2H, dt, J = 4.5 Hz 
and 11.0 Hz, H-2’’’ and H-3’’’); 13C NMR (100MHz, CDCl3); 5.3 (C-1’’’), 6.5 (C-2’’’ and C-3’’’’), 42.7 (C-2’), 
45.7 (C-1’), 107.8 (C-4), 114.1 (C-7), 118.5 (C-5), 119.8 (C-5’’), 120.7 (ArC), 122.0 (ArC), 137.6 (ArC), 142.7 
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Using the general procedure; to a solution of azide 6 (0.21 g, 0.68 mmol, 1.0 equiv.) and 
cyclopentylacetylene (0.1 mL, 1.02 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was 
added 0.7 mL 1M CuSO4 (aq) and 1.4 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was 
stirred at 20 °C for 2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-
cyclopentyl-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5az, 0.16 g, 0.40 mmol, 59 %) 
as an off white solid; Rf 0.13 (100 % EtOAc), m.p. 174 - 179 °C; IR νmax/cm-1 3248, 3078, 2948, 1600, 1579, 
1484, 1261; 1H NMR (400MHz, CDCl3); 7.09 (1H, s, H-7), 7.01 (1H, s, H-5’’), 6.91 (1H, dd, J = 1.5 Hz and 
9.0 Hz, H-5). 6.29 (1H, d, J = 9.0 Hz, H-4), 4.73 (2H, t, J 5.5 Hz, H-1’), 4.37 (2H, t, J = 6.0 Hz, H-2’), 3.01 
(1H, quin, J = 8.0 Hz, H-1’’’), 1.94 - 1.86 (2H, m, H-2’’’ and H-5’’’), 1.63 - 1.53 (4H, m, H-3’’’ and H-4’’’), 1.44 - 
1.32 (2H, m, H-2’’’ and H-5’’’); 13C NMR (100MHz, CDCl3); 23.9 (C-3’’’ and C-4’’’), 32.1 (C-2’’’ and C-5’’’), 
35.4 (C-1’’’), 42.9 (C-2’), 45.7 (C-1’), 107.8 (C-4), 114.0 (C-7), 118.8 (C-5), 119.8 (C-5’’), 120.7 (ArC), 121.9 
(ArC), 137.7 (ArC), 142.7 (Ar(OCF3)), 152.2 (ArC), 159.6 (ArC); MS m/z [M+H]+ C17H19F3N5Os requires 
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3-(2-(4-Cyclohexyl-1,2,3-triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine 5aaa  
 
Using the general procedure; to a solution of azide 6 (0.23 g, 0.75 mmol, 1.0 equiv.) and cyclohexylacetylene 
(0.2 mL, 1.12 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.8 mL 1M 
CuSO4 (aq) and 1.5 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 
2 h.  After work-up the crude was column purified using 100 % EtOAc to yield 3-(2-(4-cyclohexyl-1,2,3-
triazol-1-yl)ethyl)-6-(trifluoromethoxy)benzothiazol-2-imine (5aaa, 0.17 g, 0.41 mmol, 55 %) as a pale yellow 
solid; Rf 0.15 (100 % EtOAc), m.p. 178 - 182 °C; IR νmax/cm-1 3220, 3028, 2925, 1581, 1483, 1254; 1H NMR 
(400MHz, CDCl3); 7.09 (1H, s, H-7), 6.99 (1H, s, H-5’’), 6.90 (1H, d, J = 9.0 Hz, H-5), 6.27 (1H, d, J = 9.0 Hz, 
H-4), 4.74 (2H, t, J = 5.5 Hz, H-1’), 4.37 (2H, t, J = 5.5 Hz, H-2’), 2.58 (1H, ttt, J = 3.5 Hz and 11.5 Hz, H-1’’’), 
1.78 - 1.75 (2H, m, H-2’’’ and H-6’’’), 1.70 -1.64 (3H, m, H-3’’’, H-4’’’ and H-5’’’), 1.35 - 1.25 (2H, m, H-2’’’ and 
H-6’’’), 1.20 - 1.06 (3H, m, H-3’’’, H-4’’’ and H-5’’’); 13C NMR (100MHz, CDCl3); 25.1 (C-3’’’, C-4’’’ and C-5’’’), 
31.9 (C-2’’’ and C-6’’’), 34.0 (C-1’’’), 42.9 (C-2’), 45.7 (C-1’), 107.8 (C-4), 114.0 (C-7), 118.1 (ArC), 118.8 (C-
5), 119.6 (C-5’’), 120.6 (ArC), 121.9 (ArC), 137.7 (ArC), 142.6 (Ar(OCF3)), 153.1 (ArC), 159.6 (ArC); MS m/z 
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Ethyl 1-(2-(2-Imino-6-(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazole-4-carboxylate 5aab 
 
Using the general procedure; to a solution of azide 6 (0.15 g, 0.48 mmol, 1.0 equiv.) and ethyl propiolate (0.1 
mL, 0.72 mmol, 1.5 equiv.) in 10.0 mL H2O and 10.0 mL THF heated to 20 °C was added 0.5 mL 1M CuSO4 
(aq) and 1.0 mL sodium ascorbate (aq., 1M, freshly prepared) dropwise.  This was stirred at 20 °C for 2 h.  
After work-up the crude was column purified using 100 % EtOAc to yield ethyl 1-(2-(2-imino-6-
(trifluoromethoxy)benzothiazol-3-yl)ethyl)-1,2,3-triazole-4-carboxylate (5aab, 0.12 g, 0.29 mmol, 61 %) as a 
pale yellow solid; Rf 0.15 (100 % EtOAc), m.p. 159 - 163 °C 
IR νmax/cm-1 3276, 3043, 2979, 1721, 1631, 1583, 1485, 1261; 1H NMR (400MHz, CDCl3); 7.95 (1H, s, H-5’), 
7.11 (1H, s, H-7’’’), 6.97 (1H, d, J = 8.5 Hz, H-5’’’), 6.49 (1H, d, J = 9.0 Hz, H-4’’’), 4.84 (2H, t, J = 6.0 Hz, H-
1’’), 4.46 (2H, t, J = 6.0 Hz, H-2’’), 4.37 (2H, q, J = 7.0 Hz, H-3), 1.37 (3H, t, J = 7.0 Hz, H-4); 13C NMR 
(100MHz, CDCl3); 14.2 (C-4), 43.3 (C-2’’), 47.2 (C-1’’), 61.4 (C-3), 108.7 (C-4’’’), 115.4 (C-7’’’), 119.9 (C-5’’’), 
121.7 (ArC), 123.4 (ArC), 128.6 (C-5’), 138.4 (ArC), 140.4 (ArC), 143.9 (Ar(OCF3)), 160.4 (ArC), 160.8 (ArC); 
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Figure 2. Primary cortical neurons treated with kainate show a loss in MAP2 fluorescence that is partly 
reversed with riluzole derivatives Primary cortical neurons were treated for 18 hours with vehicle (A) or 
kainate (50, 100 or 250 mM; B-D) then fixed and stained for MAP2. Pictures show loss of neurofilaments 
without significant cell death with 50 or 100 mM kainate. The loss of neurofilament protein MAP2 assessed 
by Western Blotting is represented graphically in E, where the AMPA antagonist CNQX (20 mM) reverses 
kainate-induced MAP2 loss. Panel F represents experiments where primary cortical neurons were pretreated 
with riluzole derivatives (1 μM) followed by 18 hours treatment with 100 μM kainate. Cells were fixed and 
stained for MAP2 with 10 images per experimental condition analysed per n using Volocity perimeter 
analysis. n=4. For data presentation, the kainate-induced loss is normalised to 1 representing an 
approximate 70% decrease from untreated control values (not shown, but refer to panel E for 
comparison).  Test compounds which led to MAP2 fluorescent levels above the red dashed line demonstrate 
the ability of compounds to partially reverse of kainate-induced MAP2 loss.  The parent, riluzole, is not 




5ap 5ao 5r 5g 5aq 5w 5ak
 Figure 3. Riluzole derivatives can preserve motor neuron morphology in response to kainate. Primary motor 
neurons were treated with A) vehicle or B) 100 µM kainate alone or treated with kainate following pre-
treatment with C) the AMPA antagonist CNQX, D) 500 nM 5ap, E) 500 nM 5ao, F) 1 µM 5g, G) 500 nM 5aq, 
H) 1 µM 5w, or I) 1 µM 5ak. Cells were fixed and stained for SMI-32. n=3.  K shows a representative pooled 
5ap
5ao
analysis, where riluzole (1 mM, K), CNQX (L), 5ao (M), 5ap (N) significantly increased the number of 
neuronal processes extending between 5-10 radii compared to kainate treatment: in the graph.  For each 
figure the black line represents vehicle treated control, the grey represents agonist treatment and the dashed 
line represents agonist treatment in the presence of riluzole. There was significant protection of kainate-
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